Scientific Program 2027

Day 1Monday, March 8, 2027

  1. Thomas J. Webster

    Eliminating cancer return with nanomedicine: Human clinical trials

    Thomas J. Webster, Brown University, United States

    This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 45,000 patients to date showing no signs…

    View Full Abstract →
  2. Franco Musio
  3. Venturi Sebastiano

    Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries

    Venturi Sebastiano, Department of Public Health of Rimini, Italy

    The global dissemination of artificial radionuclides since 1945 represents a novel environmental condition in evolutionary terms. Isotopes such as Cesium-137 (Cs-137) and Iodine-131 (I-131), generated through nuclear weapons testing, reactor accidents, and nuclear energy production, were not…

    View Full Abstract →
  4. Sergey Suchkov

    Personalized and precision medicine (PPM) through the view of bio design-inspired translational research: An option for clinical oncologists, caregivers and consumers to realize the potential of genomics-informed care to secure the human biosafety

    Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russia

    A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will permit PPM as…

    View Full Abstract →
  5. Ludmila Grzybowska Szatkowska

    Mitochondria and malignant neoplasms: the impact of mtdna variations on carcinogenesis

    Ludmila Grzybowska Szatkowska, Medical University of Lublin, Poland

    Mitochondria play a crucial role in cellular oxidation and eukaryotic cell function, possessing their own genome (mtDNA) that encodes polypeptides of the respiratory chain complexes. While the pathogenesis of neoplasms is highly complex, the role of mtDNA alterations in carcinogenesis remains…

    View Full Abstract →
  6. Sergey Suchkov

    Personalized and precision oncology (PPO) via upgraded cancer design strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer care

    Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russia

    A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). The concept of PPM is becoming increasingly relevant for cancer treatment, moving from the ‘one-size-fits-all’ standard therapy to a more…

    View Full Abstract →
  7. Lorenzo Franceschini

    A Modular Synthetic DNA Template Platform for Rapid Generation of TCR-Encoding mRNA and Streamlined Validation of Cognate TCR-Epitope Reactivity

    Lorenzo Franceschini, VUB Health campus, Brussels, Belgium

    The interaction between T-cell receptors (TCRs) and their cognate ligands plays an important role in the regulation of the adaptive immune system as this is key in inducing immune responses in cancer, infectious and autoimmune diseases. As identification of a cognate TCR relies on laborious…

    View Full Abstract →
  8. Mbella Irene Ewelisane

    Stages at diagnosis and barriers to early diagnosis of head and neck cancers in a low income setting: A 6 year retrospective study at the douala general hospital and the cameroon oncology center

    Mbella Irene Ewelisane, University of Buea, Cameroon

    Head and neck cancers (HNCs) are an increasing public health concern, particularly in low- and middle-income countries such as Cameroon. They affect vital anatomical sites, including the oral cavity, pharynx, larynx, nasal cavity, paranasal sinuses, and salivary glands. In Cameroon, the burden is…

    View Full Abstract →
  9. Rahul Hajare

    Sex based clinicopathological characteristics and survival of balloon cell melanoma: a population based seer analysis

    Rahul Hajare, Sandip University, India

    Balloon Cell Melanoma is an uncommon type of melanoma with insufficient population-level epidemiological data. The objective of this study is to examine the incidence rate, clinicopathological features, survival outcomes, and gender differences in patients diagnosed with BCM based on SEER-18…

    View Full Abstract →
  10. El Hadji Seydou Mbaye

    World program against cancer in low and middle incomes countries

    El Hadji Seydou Mbaye, International Agency for Research on Cancer Dakar, Senegal

    INTRODUCTION: Worldwide, one in eight deaths is due to cancer. Projections based on the GLOBOCAN 2012 estimates predict a substantive increase new cancer cases per year by 2035 in developing countries if preventive measures are not widely applied. According to the World Health Organization (WHO),…

    View Full Abstract →
  11. Wissal Rouabeh

    Surgical management of primary malignant chest wall tumors: Case series

    Wissal Rouabeh, Sahloul University Hospital, Tunisia

    Background: Primary malignant tumors of the chest wall are rare, accounting for approximately 5% of all thoracic tumors. Their prognosis depends mainly on histological subtype and completeness of surgical resection, and management often requires complex reconstruction to preserve chest wall…

    View Full Abstract →
  12. Wissal Rouabeh

    Recurrent right sided cardiac synovial sarcoma in a 12-year-old adolescent: A rare case and review of the literature

    Wissal Rouabeh, Sahloul University Hospital, Tunisia

    Background: Primary cardiac synovial sarcoma (CSS) is an exceptionally rare and aggressively malignant tumor, particularly in the pediatric population, where nonspecific manifestations often lead to delayed or misdiagnosis. Case Summary: We report the case of a 12-year-old boy who presented with…

    View Full Abstract →
  13. Franklin Kiplagat Koech

    Strengthening primary healthcare clinics to reduce delays in cancer care: findings from kenya

    Franklin Kiplagat Koech, African Population and Health Research Center(APHRC), Kenya

    Background: Delays in cancer care contribute to poor outcomes in Sub-Saharan Africa, including Kiambu County, Kenya. These delays occur at multiple levels, including late presentation, delayed diagnosis, inefficient referrals, and limited treatment readiness at primary healthcare facilities.…

    View Full Abstract →
  14. Inshall Nadeem

    Drug-induced oral toxicity with severe stomatitis and treatment modifications under trop-2-targeted antibody–drug conjugates in advanced solid tumors: A systematic review and meta-analysis

    Inshall Nadeem, Bahria University Health Sciences Campus, Pakistan

    Background: Trophoblast cell-surface antigen 2 (TROP-2)-directed antibody–drug conjugates (ADCs) have transformed the treatment landscape of advanced solid tumors. However, stomatitis and oral mucositis represent major dose-limiting toxicities. We synthesized evidence from randomized controlled…

    View Full Abstract →
  15. Adam Khanboubi

    The significance of diffusion-tensor imaging (DTI) and how it can help with effective treatments for brain metastases patients

    Adam Khanboubi, Dana Farber Cancer Institute, United States

    Brain metastases represent a significant challenge in cancer care, affecting approximately 150,000 to 200,000 individuals annually. Among patients with stage 4 breast cancer, an estimated 10–15% develop metastatic tumors in the brain, often requiring surgical intervention. While conventional…

    View Full Abstract →
  16. Liliya

    Stage-specific multimodal rehabilitation after breast cancer treatment: Prospective evidence across treatment-related complications

    Liliya, N.N.Petrov of MoH of Russia, Russia

    Objective : To evaluate the efficacy and safety of stage-specific multimodal rehabilitation incorporating physical therapy modalities after multimodal breast cancer (BC) treatment. Methods : Four prospective cohorts included 250 patients. At 2–4 weeks after surgery, 73 patients received therapeutic…

    View Full Abstract →
  17. DU Chengyue

    MEK1 mediate 3D specific chemoresistance to etoposide revealed by a CRISPR screen in tumor spheroids

    DU Chengyue, Hong Kong Baptist University, Hong Kong, China

    Background & Objective :Chemoresistance remains the foremost impediment to curative cancer therapy, yet its mechanistic dissection is often confounded by the reductionist nature of conventional 2D cell culture, which fails to recapitulate the architectural, hypoxic, and matrix-mediated cues of…

    View Full Abstract →
  18. Sarita Maurya

    Artificial intelligence-driven biomarker discovery in brain cancer: an integrative computational approach

    Sarita Maurya, University of Allahabad, India

    Brain cancer represents a major challenge in oncology because of its molecular heterogeneity, complex disease mechanisms, and variability in patient responses to treatment. Identification of reliable molecular biomarkers can support improved disease characterization, diagnosis, prognosis, and…

    View Full Abstract →
  19. Jamal Khan

    Impact of normalization strategies on the diagnostic performance of salivary microRNAs for early detection of oral squamous cell carcinoma: A systematic review, diagnostic meta-analysis, and meta-regression

    Jamal Khan, Khyber College of Dentistry, Pakistan

    Salivary microRNAs (miRNAs) are promising non-invasive biomarkers for the early detection of oral squamous cell carcinoma (OSCC), but variability in normalization strategies limits their reproducibility and clinical translation. This PRISMA-guided systematic review (PROSPERO: CRD420261465738)…

    View Full Abstract →
  20. Saumya Pandey

    Matrix metalloproteinase [MMP]-2 (2735C>T) and tissue inhibitor of metalloproteinase [TIMP]-2 (2418G>C) genetic variants as predictors of human papillomavirus-mediated cervical cancer amongst women of asian indian ethnicity: Immuno-oncology snapshot

    Saumya Pandey, IndiraIVF Hospital, India

    Objectives: Inflammation is a hallmark of HPV-mediated cervical cancer; Matrix metalloproteinase [MMP]-2 and tissue inhibitor of metalloproteinase [TIMP]-2 are emerging as pivotal players in inflammation and carcinogenesis. My study aimed to evaluate the role of MMP-2 (-735C>T) [rs2285053] and…

    View Full Abstract →
  21. Koustav Sarkar

    CTCF-mediated epigenetic control of T helper cell differentiation in non-small cell lung cancer

    Koustav Sarkar, SRM Institute of Science and Technology, India

    Non-small-cell-Lung-Cancer (NSCLC) remains a chief global health concern despite medical advancements. This study investigates the pivotal role of CCCTC-binding factor (CTCF), an 11-zinc finger protein acting as a transcription factor, in NSCLC progression. It can work either as a transcriptional…

    View Full Abstract →
  22. Rayan Saleh Alsaud

    Adding immune checkpoint inhibitors to locoregional therapy for unresectable intermediate-to-advanced hepatocellular carcinoma: A systematic review and network meta-analysis

    Rayan Saleh Alsaud, Qassim University, Saudi Arabia

    Background: Locoregional therapy (LRT) is the main treatment for unresectable intermediate-to-advanced hepatocellular carcinoma (HCC), but survival remains poor. Immune checkpoint inhibitors (ICIs) are now standard systemic therapy for advanced HCC. LRT can release tumour antigens and alter the…

    View Full Abstract →
  23. Dilshani Kaushalya Abeygunawardhana

    Identification of HER2 status in patients with invasive breast carcinoma at a tertiary care centre in sri lanka: A clinical audit

    Dilshani Kaushalya Abeygunawardhana, National Hospital Galle, Sri Lanka

    Introduction and objective:Molecular subtyping of invasive breast carcinomas (IBC) is crucial for patient management, predicting clinical outcome and prognostication. HER2 overexpression is seen in approximately 15–25% of IBC, which have worse prognosis than luminal tumours and require targeted…

    View Full Abstract →
  24. Ngone Gaye

    From lived experience to community advocacy: The role of cancer & vie in promoting awareness, peer support and patient navigation in senegal

    Ngone Gaye, Cancer & Vie, Senegal

    Background: Cancer affects more than physical health. It can also create emotional, social and informational challenges for patients and their families. Drawing on my experience as a cervical cancer survivor in Senegal, I founded Cancer & Vie, an independent digital initiative intended to promote…

    View Full Abstract →
  25. Kelvin Opiyo Onyango

    Factors associated with late-stage cancer diagnosis in kiambu county, kenya: apopulation-based cancer registry analysis, 2022–2025

    Kelvin Opiyo Onyango, National cancer institute of kenya, Kenya

    Background : Behind every registry record is a person whose stage at diagnosis shapes the treatment they can reach,the care their family must provide and their chance of long-term survival. In sub-Saharan Africa, late presentationremains a major barrier to cancer control, yet population-based…

    View Full Abstract →
  26. Linet Koskei

    Where women are lost between screening and treatment: same-day screen-and-treat versus deferred treatment in community cervical cancer screening outreach in kenya

    Linet Koskei, National cancer institute of kenya, Kenya

    Background : Every woman with cervical precancer is one treatment away from never developing cancer, and everymissed treatment leaves a preventable cancer to chance. Yet in 2024 only 43% of treatment-eligible women inKenya received treatment (Ministry of Health, Kenya, 2025), against the WHO…

    View Full Abstract →
  27. Asif Rauf

    Sensitivity analysis of environmental and positional parameters in HDR Ir-192 source calibration

    Asif Rauf, Shaukat Khanum Memorial Cancer Hospital, Pakistan

    Introduction : Accurate calibration of high-dose-rate (HDR) Iridium-192 (Ir-192) sources is essential for ensuring dosimetric accuracy and treatment safety in brachytherapy. Environmental and procedural factors, including temperature, atmospheric pressure, source positioning, and decay timing, may…

    View Full Abstract →